國立虎尾科技大學 |

Nanotheranostics for Cancer Applications

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Nanotheranostics for Cancer Applications/ edited by Prakash Rai, Stephanie A. Morris.
其他作者:	Rai, Prakash.
面頁冊數:	XIV, 480 p. 89 illus., 83 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Biomedical engineering. -
電子資源:	https://doi.org/10.1007/978-3-030-01775-0
ISBN:	9783030017750

Nanotheranostics for Cancer Applications
Nanotheranostics for Cancer Applications[electronic resource] /edited by Prakash Rai, Stephanie A. Morris. - 1st ed. 2019. - XIV, 480 p. 89 illus., 83 illus. in color.online resource. - Bioanalysis, Advanced Materials, Methods, and Devices,52364-1118 ;. - Bioanalysis, Advanced Materials, Methods, and Devices,5.

About the Editors -- List of Contributors -- Part I Introduction to Cancer and Nanotechnology -- 1 Introduction -- 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics -- 3 Cancer Diagnostics and Therapeutics -- 4 Nanomedicine in Cancer -- 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications -- Part II Cancer Nanodiagnostics and Nanotherapeutics -- 6 In Vitro Cancer Diagnostics -- 7 Translational Nanodiagnostics for In Vivo Cancer Detection -- 8 Delivery of Cancer Nanotherapeutics -- 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations -- 10 Topical and Transdermal Nanomedicines for Cancer Therapy -- 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes -- Part III Regulatory Considerations for Nanomaterial Drug Products -- 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials -- 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials -- Part IV Cancer Nanotheranostics -- 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging -- 15 Image-Guided Drug Delivery -- 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring -- 17 Remotely-Triggered Nanotheranostics -- 18 Concluding Remarks and the Future of Nanotheranostics -- Index.

This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotely triggered drug delivery systems to limit cytotoxicity in the diseased area. This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the challenges and limitations of conventional cancer treatments, and presents an overview of the use of nanotechnology in treating cancer. These introductory chapters are followed by those exploring cancer diagnosis and a myriad of delivery methods for nanotherapeutics. The book also addresses multifunctional platforms, treatment monitoring, and regulatory considerations. As a whole, the book aims to briefly summarize the development and clinical potential of various nanotheranostics for cancer applications, and to delineate the challenges that must be overcome for successful clinical development and implementation of such cancer theranostics. Provides a comprehensive review of cancer nanotheranostics Represents the first book-length treatment of the topic Presents a full picture of the field, from basic research through clinical implementation Features evidence-based chapters with excellent illustrations and images to guide and assist the reader.

ISBN: 9783030017750

Standard No.: 10.1007/978-3-030-01775-0doiSubjects--Topical Terms:

588770
Biomedical engineering.

LC Class. No.: R856-857

Dewey Class. No.: 610.28

Nanotheranostics for Cancer Applications
LDR:04972nam a22004215i 4500 001 1006574
003 DE-He213
005 20200702074942.0
007 cr nn 008mamaa
008 210106s2019 gw | s |||| 0|eng d
020 $a 9783030017750 $9 978-3-030-01775-0
024 7 $a 10.1007/978-3-030-01775-0 $2 doi
035 $a 978-3-030-01775-0
050 4 $a R856-857
050 4 $a HC79.E5
050 4 $a GE220
072 7 $a MQW $2 bicssc
072 7 $a TEC059000 $2 bisacsh
072 7 $a MQW $2 thema
082 0 4 $a 610.28 $2 23
245 1 0 $a Nanotheranostics for Cancer Applications $h [electronic resource] / $c edited by Prakash Rai, Stephanie A. Morris.
250 $a 1st ed. 2019.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a XIV, 480 p. 89 illus., 83 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Bioanalysis, Advanced Materials, Methods, and Devices, $x 2364-1118 ; $v 5
505 0 $a About the Editors -- List of Contributors -- Part I Introduction to Cancer and Nanotechnology -- 1 Introduction -- 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics -- 3 Cancer Diagnostics and Therapeutics -- 4 Nanomedicine in Cancer -- 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications -- Part II Cancer Nanodiagnostics and Nanotherapeutics -- 6 In Vitro Cancer Diagnostics -- 7 Translational Nanodiagnostics for In Vivo Cancer Detection -- 8 Delivery of Cancer Nanotherapeutics -- 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations -- 10 Topical and Transdermal Nanomedicines for Cancer Therapy -- 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes -- Part III Regulatory Considerations for Nanomaterial Drug Products -- 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials -- 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials -- Part IV Cancer Nanotheranostics -- 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging -- 15 Image-Guided Drug Delivery -- 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring -- 17 Remotely-Triggered Nanotheranostics -- 18 Concluding Remarks and the Future of Nanotheranostics -- Index.
520 $a This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose and treat a disease, is a nascent field that is growing rapidly in this era of personalized medicine. As the need for cost-effective disease diagnosis grows, drug delivery systems that can act as multifunctional carriers for imaging contrast and therapy agents could provide unique breakthroughs in oncology. Nanotechnology has enabled the development of smart theranostic platforms that can concurrently diagnose disease, start primary treatment, monitor response and initiate secondary treatments if required. In oncology, chemotherapeutics have been routinely used. Some drugs have proven effective but all carry risks of adverse side effects. There is growing interest in using remotely triggered drug delivery systems to limit cytotoxicity in the diseased area. This book reviews the use of theranostic nanoparticles for cancer applications over the past decade. First, it briefly discusses the challenges and limitations of conventional cancer treatments, and presents an overview of the use of nanotechnology in treating cancer. These introductory chapters are followed by those exploring cancer diagnosis and a myriad of delivery methods for nanotherapeutics. The book also addresses multifunctional platforms, treatment monitoring, and regulatory considerations. As a whole, the book aims to briefly summarize the development and clinical potential of various nanotheranostics for cancer applications, and to delineate the challenges that must be overcome for successful clinical development and implementation of such cancer theranostics. Provides a comprehensive review of cancer nanotheranostics Represents the first book-length treatment of the topic Presents a full picture of the field, from basic research through clinical implementation Features evidence-based chapters with excellent illustrations and images to guide and assist the reader.
650 0 $a Biomedical engineering. $3 588770
650 0 $a Oncology . $3 1253469
650 0 $a Nanochemistry. $3 596891
650 0 $a Biomaterials. $3 677000
650 0 $a Pharmaceutical technology. $3 557391
650 0 $a Biophysics. $3 581576
650 0 $a Biological physics. $3 1253579
650 1 4 $a Biomedical Engineering and Bioengineering. $3 1211019
650 2 4 $a Oncology. $3 593951
650 2 4 $a Pharmaceutical Sciences/Technology. $3 768561
650 2 4 $a Biological and Medical Physics, Biophysics. $3 1113305
700 1 $a Rai, Prakash. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1300151
700 1 $a Morris, Stephanie A. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1300152
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030017736
776 0 8 $i Printed edition: $z 9783030017743
830 0 $a Bioanalysis, Advanced Materials, Methods, and Devices, $x 2364-1118 ; $v 5 $3 1300153
856 4 0 $u https://doi.org/10.1007/978-3-030-01775-0
912 $a ZDB-2-ENG
912 $a ZDB-2-SXE
950 $a Engineering (SpringerNature-11647)
950 $a Engineering (R0) (SpringerNature-43712)